WallStSmart

Edwards Lifesciences Corp (EW)vsInteger Holdings Corp (ITGR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Edwards Lifesciences Corp generates 240% more annual revenue ($6.30B vs $1.86B). EW leads profitability with a 17.4% profit margin vs 7.6%. EW appears more attractively valued with a PEG of 2.15. EW earns a higher WallStSmart Score of 59/100 (C).

EW

Buy

59

out of 100

Grade: C

Growth: 6.0Profit: 8.0Value: 6.0Quality: 8.5
Piotroski: 3/9Altman Z: 4.48

ITGR

Buy

58

out of 100

Grade: C

Growth: 7.3Profit: 5.5Value: 5.3Quality: 6.5
Piotroski: 3/9Altman Z: 1.93
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

EWUndervalued (+68.6%)

Margin of Safety

+68.6%

Fair Value

$252.36

Current Price

$90.78

$161.58 discount

UndervaluedFair: $252.36Overvalued
ITGRUndervalued (+8.0%)

Margin of Safety

+8.0%

Fair Value

$94.78

Current Price

$93.89

$0.89 discount

UndervaluedFair: $94.78Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

EW5 strengths · Avg: 9.4/10
Operating MarginProfitability
31.2%10/10

Strong operational efficiency at 31.2%

Debt/EquityHealth
0.0710/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
4.4810/10

Safe zone — low bankruptcy risk

Market CapQuality
$51.66B9/10

Large-cap with strong market position

Revenue GrowthGrowth
16.7%8/10

16.7% revenue growth

ITGR2 strengths · Avg: 9.0/10
EPS GrowthGrowth
52.9%10/10

Earnings expanding 52.9% YoY

Price/BookValuation
1.9x8/10

Reasonable price relative to book value

Areas to Watch

EW4 concerns · Avg: 2.8/10
PEG RatioValuation
2.154/10

Expensive relative to growth rate

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

P/E RatioValuation
48.5x2/10

Premium valuation, high expectations priced in

Free Cash FlowQuality
$-21.10M2/10

Negative free cash flow — burning cash

ITGR4 concerns · Avg: 3.8/10
PEG RatioValuation
2.494/10

Expensive relative to growth rate

Revenue GrowthGrowth
0.5%4/10

0.5% revenue growth

Altman Z-ScoreHealth
1.934/10

Grey zone — moderate risk

Profit MarginProfitability
7.6%3/10

7.6% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : EW

The strongest argument for EW centers on Operating Margin, Debt/Equity, Altman Z-Score. Profitability is solid with margins at 17.4% and operating margin at 31.2%. Revenue growth of 16.7% demonstrates continued momentum.

Bull Case : ITGR

The strongest argument for ITGR centers on EPS Growth, Price/Book.

Bear Case : EW

The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 48.5x leaves little room for execution misses.

Bear Case : ITGR

The primary concerns for ITGR are PEG Ratio, Revenue Growth, Altman Z-Score.

Key Dynamics to Monitor

EW profiles as a growth stock while ITGR is a value play — different risk/reward profiles.

EW carries more volatility with a beta of 0.87 — expect wider price swings.

EW is growing revenue faster at 16.7% — sustainability is the question.

ITGR generates stronger free cash flow (737,000), providing more financial flexibility.

Bottom Line

EW scores higher overall (59/100 vs 58/100), backed by strong 17.4% margins and 16.7% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Edwards Lifesciences Corp

HEALTHCARE · MEDICAL DEVICES · USA

Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.

Visit Website →

Integer Holdings Corp

HEALTHCARE · MEDICAL DEVICES · USA

Integer Holdings Corporation is an outsourced manufacturer of medical devices in the United States, Puerto Rico, Costa Rica, and internationally. The company is headquartered in Plano, Texas.

Want to dig deeper into these stocks?